Dr. Ashok Srivastava is Chief Executive Officer and Chief Medical Officer of Cure Pharmaceuticals, and ClinFomatrix Oncology CRO, He was founder, Chief Executive Officer and Chief Medical Officer of CareBeyond - A Radiation Therapy Cancer Center, New Jersey. USA. He has more than 15 years of experience in drug development, medical affairs and commercialization of cancer drugs including radiopharmaceutical and supportive care; Phase 1 Ė 4, and marketing commercialization of Hematology, Oncology and radio-immuno-oncology drugs in USA, EU and Japan.
Jan Jacques Michiels is Multidisciplinary Internist of Blood Coagulation & Vascular Medicine Center, Erasmus Tower, Veenmos, Professor of Nature Medicine & Health Clinical and Molecular Genetics at Blood & Coagulation Research, University Hospitals Antwerp, Brussels and Martin-Bratislava. He is International Consultant of Blood Coagulation & Vascular Medicine and Consultant of Academic, Pharmaceutical and Industrial Medicine. He is Editor of Journal of Hematology & Thromboembolic Diseases, World Journal of Hematology and Editor in Chief of World Journal of Clinical Cases. He is interested in stem cell transplantation and hematology research
Dr. Ian James Martins is an Editor/Reveiwer for Open Acess Pub/MDPI journals and various other international journals. Advisory Board Member for Photon Journal. Fellow of International Agency for Standards and Ratings (IASR). Conferred with the RICHARD KUHN RESEARCH AWARD-2015 ENDOCRINOLOGY AND METABOLISM. Chief Editor for International Journal of Diabetes Research (2014-2018), Research and Reviews: Neuroscience (2016-2018) and Journal of Diabetes and Clinical Studies (2017-2018). BIT Member (BIT Congress. Inc) with an h-index of 65, (ResearchGate STATs (28), Scopus Author ID: 7103152779/Mendeley STATS (21), UWA Research Repository (16). Scientist for The Science Advisory Board (USA) and an Academic with Academia.edu. The citations past 27 years have accumulated to.
Noemi Tirado Bustillos is professor of Biochemistry and Molecular Biology at Universidad Mayor de San Andres (UMSA), Head of Genotoxicology Unit at Genetic Institute Medicine School UMSA La Paz Bolivia.
Vice president of the Executive Committee of the Latin American Association of Mutagenesis, Carcinogenesis and Environmental Teratogenesis, (ALAMCTA). President of the Bolivian Society of Mutagenesis, Carcinogenesis and Environmental Teratogenesis (SBOMCTA).
She is the coordinator of a research regarding environmental toxicology studies (pesticide exposure) Swedish cooperation, Bolivian coordinator of a grant related to Arsenic Methabolism in women exposed to contaminated drinking water, she is the author/co-author of scientific papers, research papers, all of them concerning biomonitoring of people exposed to environment contaminants as Heavy metals, pesticides, chemicals (131I, Formaldehyde) and radiations, and conferences worldwide. She is recipient of several national and international awardall, Chairperson of The XIX International A. Hollaender Courses by the IAEMS 2015, Member of Organizing Committee of X ALAMCTA Congress 2016- Uruguay, Member of Organizing Committee of 17th International Conference on Environmental Toxicology and Ecological Risk assessment 2018 Chicago Illinois, Member of Organizing Committee of X ALAMCTA Congress 2019 Paraguay.
Dr. Kathleen Meehan worked as a Principal Medical Technologist, Provincial Laboratory for Tissue Immunology, South Africa 1983-1995, Lecturer, Senior Lecturer, Cape Peninsula University of Technology, South Africa: Faculty Health Sciences Jan 1996-Aug 2005, Associate Professor Cape Peninsula University of Technology, South Africa Faculty Health Sciences Aug 2005-Aug 2006, Faculty HCT: Medical Laboratory Technology Aug 2006-Jan 2007, Program co-ordinator HCT: Medical Laboratory Technology, Medical Imaging, Pharmacy and Nursing Feb 2007-Jan 2010, Chair HCT: Health Science Faculty. Dean Health Sciences, SEHA Feb 2010-Jan 2012, Associate Dean Higher Colleges of Technology (HCT): Health Science Feb 2012-Aug 2015, Head of Dept; Assoc. Prof, Health and Medical Sciences, Khawarizmi International University College Sep 2015- Dec 2017, Director: External Academic Relations, Khawarizmi International University College Jan 2018-current. She was awarded the AA Wadee memorial Gold Medal most promising young scientist, SA, 1992, J&J Platinum awar exceptional achievement in field of immunology, SA,1997, Mutagenesis prize most outstanding presentation by a young scientist, (Int) France, 1997, Most promising new researcher, CPUT, (first recipient) SA, 1999, Young Investigators Award Radiobiology Society,(Int), SA, 2000, SA Ass of Women Graduates - Award of Excellence, SA, 2001, SocMedLabTechSA Best doctoral student, SA, 2002, SA Ass Physicists Medicine Biology (SAAPMB) best overall presentation, SA, 2004, Fogarty Scholarship, Int Centre,NIH Full scholarship for University of Cape Town: Post graduate diploma in International Research Ethics, 2004, Nominee HAAD Medical Distinction Award, 2011; 2013.
Ahmed G Hegazi worked as a Professor of Microbiology & Immunology, National Research Center, Dept. Parasitology, 1997-2000, Chair of Faculty of Medicine, Zagazig University, 1981-1997, part-time Professor and Supervisor of Immunology Section, National Research Center, 1990- up till now. He is also Prof. of Microbiology & Immunology, African Federation of Apiculture Associations (AFAA), 2001- up till now, Standing Commission on Apitherapy (APIMONDIA), 1999 - up till now, Member of Standing Scientific Committee, National Research Center, 1998 -up till now. He was awarded the Excellent Medal of the First Class, 1995, received the Senior Scientist Prize of National Research Center, 1996, and won The Second Best Research Paper award from International Congress of Propolis, Argentina, 2000. He has published in Egyptian Journal of Immunology, 1995, was in the Editorial Board of The Egyptian Association of Immunologists, 1992-1997, Secretary General, Referee in 37 international journals patents: 4 Patents Educational Activities. He has published 193 articles in national and international scientific journals, 6 books in English and 7 books in Arabic.
35 Research papers have been published in many reputed journals, She is Academic visitor as a international speaker to several countries as Uk, USA, Thailand, sri Lanka, UAE, Netherlands, Canada, etec.
Lim Yoon Pin is one of pioneers to develop and apply cutting-edge liquid chromatography/mass spectrometry-based phosphoproteomic technologies to oncogenic signalling and cancer research. He has published close to 50 peer-reviewed articles in the area of signal transduction, cancer research and biomarker discovery. He has filed close to 30 patents and holds 9 patents from USA, China and Singapore. The rest are pending award. Three of his inventions have been licensed and commercialized by MNC and SME.
Through phosphoproteomics, he discovered WBP2, WW domain binding protein 2, to be a novel breast cancer associated protein and a substrate of the well-known EGF Receptor Tyrosine Kinase oncogene. Subsequently, he demonstrated WBP2 to be an oncogene that works by activating multiple oncogenic pathways such as Estrogen Receptor and Wnt signalling. His lab is expanding WBP2 research to other epithelial cancers and signalling pathways like Hippo signalling. Along with Hong Wanjin, Lim Yoon Pin is one of the first to prove WBP2 as a breast cancer oncogene. His labís efforts in WBP2 research and its impact on the Wnt and Hippo signalling are recognised internationally. He works with collaborators from Australia, Germany, USA and Singapore.